Business Wire

OSE Immunotherapeutics Announces New US Patent Granted for the Use of Tedopi® in Cancer ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) today announced that the United States Patent and Trademark Office has granted a new patent ...
Business Wire

OSE Immunotherapeutics Receives First Notice of Allowance of a Patent for Use of Tedopi ...

NANTES, France--(BUSINESS WIRE)--Regulatory News: OSE Immunotherapeutics (ISIN: FR0012127173; Mnémo: OSE) (Paris:OSE), today announced that the Japanese Patent Office has issued the notice of ...